2023 Q2 Form 10-Q Financial Statement

#000129894623000046 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $291.2M $243.6M $196.8M
YoY Change 3.5% 23.74% 169.87%
Cost Of Revenue $199.7M $179.7M $144.9M
YoY Change 11.66% 24.03% 92.95%
Gross Profit $91.56M $63.82M $51.93M
YoY Change -10.74% 22.9% -2572.71%
Gross Profit Margin 31.44% 26.2% 26.38%
Selling, General & Admin $8.284M $10.64M $9.049M
YoY Change -28.05% 17.55% -9.51%
% of Gross Profit 9.05% 16.67% 17.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $27.84M $27.47M $26.66M
YoY Change 1.65% 3.07% -1.28%
% of Gross Profit 30.41% 43.05% 51.33%
Operating Expenses $36.12M $38.11M $35.70M
YoY Change -7.14% 6.74% -3.24%
Operating Profit $55.43M $25.71M $16.22M
YoY Change -12.94% 58.48% -141.6%
Interest Expense -$15.05M $17.17M $4.119M
YoY Change -255.5% 316.9% -51.45%
% of Operating Profit -27.14% 66.79% 25.39%
Other Income/Expense, Net -$15.05M -$16.75M -$4.405M
YoY Change 46.34% 280.23% -47.11%
Pretax Income $39.56M $8.962M $10.01M
YoY Change -25.91% -10.43% -105.89%
Income Tax $422.0K -$226.0K -$54.00K
% Of Pretax Income 1.07% -2.52% -0.54%
Net Earnings $36.51M $9.156M $10.03M
YoY Change -30.48% -8.7% -105.87%
Net Earnings / Revenue 12.54% 3.76% 5.09%
Basic Earnings Per Share $0.17 $0.03 $0.04
Diluted Earnings Per Share $0.17 $0.03 $0.04
COMMON SHARES
Basic Shares Outstanding 209.8M shares 209.6M shares 212.5M shares
Diluted Shares Outstanding 212.2M shares 211.8M shares 213.2M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.56M $76.50M $41.58M
YoY Change 37.43% 83.99% -58.34%
Cash & Equivalents $98.56M $76.50M $41.58M
Short-Term Investments
Other Short-Term Assets $86.22M $70.66M $98.38M
YoY Change 27.44% -28.18% 303.18%
Inventory
Prepaid Expenses
Receivables $164.2M $149.0M $154.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $349.0M $296.2M $294.2M
YoY Change 11.22% 0.68% 49.77%
LONG-TERM ASSETS
Property, Plant & Equipment $2.838B $2.743B $2.659B
YoY Change 5.55% 3.14% -0.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $37.54M $46.04M $38.88M
YoY Change -11.38% 18.41% 61.34%
Total Long-Term Assets $2.876B $2.887B $2.795B
YoY Change 1.58% 3.3% -0.09%
TOTAL ASSETS
Total Short-Term Assets $349.0M $296.2M $294.2M
Total Long-Term Assets $2.876B $2.887B $2.795B
Total Assets $3.225B $3.184B $3.089B
YoY Change 2.54% 3.05% 3.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $159.5M $151.2M $102.9M
YoY Change 50.42% 46.97% 25.77%
Accrued Expenses $111.2M $111.4M $109.1M
YoY Change 1.39% 2.1% 3.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $277.2M $269.1M $212.0M
YoY Change 81.32% 26.93% 46.53%
LONG-TERM LIABILITIES
Long-Term Debt $1.181B $1.184B $1.174B
YoY Change 0.98% 0.85% 7.7%
Other Long-Term Liabilities $136.1M $135.5M $133.4M
YoY Change 1.57% 1.62% 0.51%
Total Long-Term Liabilities $1.317B $1.319B $1.307B
YoY Change 1.04% 0.93% 6.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $277.2M $269.1M $212.0M
Total Long-Term Liabilities $1.317B $1.319B $1.307B
Total Liabilities $1.601B $1.588B $1.560B
YoY Change 2.47% 1.79% 7.69%
SHAREHOLDERS EQUITY
Retained Earnings -$670.1M -$700.3M -$773.4M
YoY Change -7.36% -9.45% 3.14%
Common Stock $2.289B $2.289B $2.296B
YoY Change -0.41% -0.32% 0.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.623B $1.589B $1.523B
YoY Change
Total Liabilities & Shareholders Equity $3.225B $3.184B $3.089B
YoY Change 2.54% 3.05% 3.18%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $36.51M $9.156M $10.03M
YoY Change -30.48% -8.7% -105.87%
Depreciation, Depletion And Amortization $27.84M $27.47M $26.66M
YoY Change 1.65% 3.07% -1.28%
Cash From Operating Activities $56.36M $58.07M $13.15M
YoY Change -9.59% 341.46% -137.64%
INVESTING ACTIVITIES
Capital Expenditures $28.12M $21.64M -$75.69M
YoY Change -148.04% -128.59% 530.74%
Acquisitions
YoY Change
Other Investing Activities -$1.500M $0.00 -$35.18M
YoY Change -104.15% -100.0%
Cash From Investing Activities -$29.62M -$21.64M -$110.9M
YoY Change 32.53% -80.48% 827.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.19M -$21.06M $102.7M
YoY Change 106.72% -120.52% 185.19%
NET CHANGE
Cash From Operating Activities 56.36M $58.07M $13.15M
Cash From Investing Activities -29.62M -$21.64M -$110.9M
Cash From Financing Activities -13.19M -$21.06M $102.7M
Net Change In Cash 13.55M $15.36M $4.956M
YoY Change -59.68% 210.01% -145.47%
FREE CASH FLOW
Cash From Operating Activities $56.36M $58.07M $13.15M
Capital Expenditures $28.12M $21.64M -$75.69M
Free Cash Flow $28.24M $36.43M $88.84M
YoY Change -76.63% -59.0% -487.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001298946
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-32514
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
DIAMONDROCK HOSPITALITY CO
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1180098
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2 Bethesda Metro Center, Suite 1400,
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
CY2023Q1 dei City Area Code
CityAreaCode
240
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
744-1150
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
209789192 shares
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2742565000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2748476000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
98747000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
99047000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
46039000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
39614000 usd
CY2023Q1 drh Due From Managers
DueFromManagers
149005000 usd
CY2022Q4 drh Due From Managers
DueFromManagers
176708000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
70657000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
76131000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76503000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67564000 usd
CY2023Q1 us-gaap Assets
Assets
3183516000 usd
CY2022Q4 us-gaap Assets
Assets
3207540000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
384374000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
386655000 usd
CY2023Q1 us-gaap Loans Payable
LoansPayable
799204000 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
799138000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1183578000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1185793000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
111437000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
110875000 usd
CY2023Q1 drh Due To Managers
DueToManagers
110270000 usd
CY2022Q4 drh Due To Managers
DueToManagers
123682000 usd
CY2023Q1 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
66205000 usd
CY2022Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
65097000 usd
CY2023Q1 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
60654000 usd
CY2022Q4 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
61069000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
40927000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
43120000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
6500000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
12946000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8672000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8780000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1588243000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1611362000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08250
CY2023Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08250
CY2022Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
25.00
CY2023Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
25.00
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4760000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4760000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4760000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4760000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
48000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
48000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
209789192 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
209789192 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
209374830 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
209374830 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2098000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2094000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2286824000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2288433000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
153000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-700287000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-700694000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1588836000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1589881000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
6437000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
6297000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1595273000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1596178000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3183516000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3207540000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243553000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
196833000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
27472000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
26655000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2843000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7867000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6033000 usd
CY2023Q1 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
0 usd
CY2022Q1 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
499000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
217842000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
182422000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
17172000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
4119000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
423000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-286000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16749000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4405000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8962000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10006000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-226000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9188000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10060000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
32000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
32000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9156000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10028000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2454000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2454000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6702000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7574000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9188000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10060000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-84000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
237000 usd
CY2022Q1 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9341000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10060000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
32000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
32000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9309000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10028000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1596178000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.03
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6327000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5156
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2454000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1967000 usd
CY2023Q1 drh Stock Redeemed To Satisfy Withholdings On Vested Share Based Compensation Value
StockRedeemedToSatisfyWithholdingsOnVestedShareBasedCompensationValue
3023000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
409000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-84000 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
237000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9188000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1595273000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1520964000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5156
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2454000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1160000 usd
CY2022Q1 drh Stock Redeemed To Satisfy Withholdings On Vested Share Based Compensation Value
StockRedeemedToSatisfyWithholdingsOnVestedShareBasedCompensationValue
810000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10060000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1528920000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9188000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10060000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
27472000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
26655000 usd
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
50000 usd
CY2022Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
59000 usd
CY2023Q1 drh Non Cash Lease Expense And Other Amortization
NonCashLeaseExpenseAndOtherAmortization
1550000 usd
CY2022Q1 drh Non Cash Lease Expense And Other Amortization
NonCashLeaseExpenseAndOtherAmortization
1568000 usd
CY2023Q1 drh Fair Value Adjustment Of Derivative Instruments
FairValueAdjustmentOfDerivativeInstruments
2014000 usd
CY2022Q1 drh Fair Value Adjustment Of Derivative Instruments
FairValueAdjustmentOfDerivativeInstruments
-7502000 usd
CY2023Q1 drh Amortization Of Financing Costs And Derivative Gains Losses
AmortizationOfFinancingCostsAndDerivativeGainsLosses
513000 usd
CY2022Q1 drh Amortization Of Financing Costs And Derivative Gains Losses
AmortizationOfFinancingCostsAndDerivativeGainsLosses
653000 usd
CY2023Q1 drh Impairment Charges Included In Continuing And Discontinued Operations
ImpairmentChargesIncludedInContinuingAndDiscontinuedOperations
0 usd
CY2022Q1 drh Impairment Charges Included In Continuing And Discontinued Operations
ImpairmentChargesIncludedInContinuingAndDiscontinuedOperations
2843000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
108000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
99000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1967000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1160000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5123000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-248000 usd
CY2023Q1 drh Increase Decrease In Due To From Hotel Managers
IncreaseDecreaseInDueToFromHotelManagers
-14291000 usd
CY2022Q1 drh Increase Decrease In Due To From Hotel Managers
IncreaseDecreaseInDueToFromHotelManagers
16934000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3991000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5557000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
58069000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13154000 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
21642000 usd
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
11628000 usd
CY2023Q1 us-gaap Payments To Acquire Other Real Estate
PaymentsToAcquireOtherRealEstate
0 usd
CY2022Q1 us-gaap Payments To Acquire Other Real Estate
PaymentsToAcquireOtherRealEstate
64061000 usd
CY2023Q1 drh Payments For Purchase Deposits
PaymentsForPurchaseDeposits
0 usd
CY2022Q1 drh Payments For Purchase Deposits
PaymentsForPurchaseDeposits
36180000 usd
CY2023Q1 drh Proceeds From Receipt Of Deferred Key Money
ProceedsFromReceiptOfDeferredKeyMoney
0 usd
CY2022Q1 drh Proceeds From Receipt Of Deferred Key Money
ProceedsFromReceiptOfDeferredKeyMoney
1000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21642000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110869000 usd
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
2404000 usd
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
3935000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 usd
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
110000000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
120000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12773000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2454000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2454000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
409000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3023000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
810000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21063000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
102671000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15364000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4956000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107178000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75507000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122542000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80463000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
14368000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
10549000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
6500000 usd
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
9000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7711000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10422000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76503000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67564000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
46039000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
39614000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122542000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107178000 usd
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
35 hotel
CY2023Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
9607 room
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassification</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications did not effect the Company's financial position, results of operations, or cash flows.</span></div>
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2019Q4 drh Common Unit Issuance Value Per Share
CommonUnitIssuanceValuePerShare
11.76
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14500000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11000000 usd
CY2023Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of our cash and cash equivalents. We maintain cash and cash equivalents with various financial institutions. We perform periodic evaluations of the relative credit standing of these financial institutions and limit the amount of credit exposure with any one institution.</span></div>
CY2023Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0488
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3964178000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3942832000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1221613000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1194356000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2742565000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2748476000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7700000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1183578000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1185793000 usd
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
35 hotel
CY2023Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
-100000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P64Y
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0577
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2770000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2786000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
340000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
230000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
983000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
985000 usd
CY2023Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08250
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08250
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2975000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4012000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4072000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4640000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4783000 usd
CY2023Q1 drh Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
754898000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
775380000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
663943000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
111437000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 drh Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q4 drh Operating Partnership Units Option To Redeem For Common Stock Ratio
OperatingPartnershipUnitsOptionToRedeemForCommonStockRatio
1
CY2018Q4 drh Operating Partnership Units Option To Redeem For Common Stock Ratio
OperatingPartnershipUnitsOptionToRedeemForCommonStockRatio
1
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.06
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
0.515625
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212491561 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211814722 shares
CY2023Q1 drh Share Based Compensation Arrangement By Share Based Payment Award Conversion Ratio
ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRatio
1
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6702000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7574000 usd
CY2023Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
0 usd
CY2022Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
0 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
6702000 usd
CY2022Q1 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
7574000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211411519 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213150818 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04

Files In Submission

Name View Source Status
0001298946-23-000046-index-headers.html Edgar Link pending
0001298946-23-000046-index.html Edgar Link pending
0001298946-23-000046.txt Edgar Link pending
0001298946-23-000046-xbrl.zip Edgar Link pending
drh-20230331.htm Edgar Link pending
drh-20230331.xsd Edgar Link pending
drh_exhibit311xmarch312023.htm Edgar Link pending
drh_exhibit312xmarch312023.htm Edgar Link pending
drh_exhibit321xmarch312023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
drh-20230331_lab.xml Edgar Link unprocessable
drh-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
drh-20230331_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
drh-20230331_def.xml Edgar Link unprocessable
drh-20230331_pre.xml Edgar Link unprocessable